Login 
Learn & Earn 
Home
നിക്ഷേപകരുടെ സംശയങ്ങൾക്ക് ഉള്ള മറുപടി..
|
Sensex surges 482 points on buying in banking, IT stocks|
BHEL reports Rs 149 crore net loss in Q3|
Kalyani Steel to invest Rs 26,000 crore in Odisha|
NCLT extends deadline for Go First's insolvency for another 60 days|
LDF Govt's choice for costly power lands KSEB in mess; accuses UDF|
Tata's Nexon.ev and Tiago.ev become cheaper by up to Rs 1.2 lakh|
Coal import rose 27% to 23.35 Million Tonne in December|
Stocks shed early gains on mixed global cues|
Micro finance sector claims it has credit outsanding potential of Rs 13 lakh crore|
Retail inflation eases to 3-month low of 5.1% in January|
Gold remains steady, Silver adds Rs 400|
Pharma
USFDA nod for Lupin to market its hypertension drug in America.
The product will be manufactured at the company's Pithampur-based manufacturing plant, the drug firm stated.
PTI 14 Jan 2024 11:02 AM GMT
Divi's Labs Q4 PAT at ₹320.97 crore, down 64.1 percent from ₹894.64 crore a year ago
20 May 2023 1:15 PM GMT
Sun Pharma, Hetero recall drugs in the US market for manufacturing issues
23 April 2023 6:30 AM GMT
Alembic Pharma receives 2 observations for Gujarat facility from USFDA
25 March 2023 6:15 AM GMT
